Novavax

NVAX • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $93,855 $291,342 $22,064 $424,426
Gross Profit 45,046 142,466 -76,865 368,649
EBITDA -126,584 -172,774 -117,293 71,056
EBIT -138,731 -183,568 -128,614 60,989
Net Income -147,550 -178,389 -130,776 58,008
Net Change In Cash 93,855 291,342 22,064 424,426
Free Cash Flow -90,805 -185,859 -58,046 -179,717
Cash 491,041 578,929 651,104 505,912
Basic Shares 139,916 123,679 103,429 104,065

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $983,705 $1,598,951 $1,146,290 $475,598
Gross Profit 704,237 696,312 1,146,290 475,598
EBITDA -373,802 -633,767 -1,673,915 -411,834
EBIT -415,027 -644,736 -1,686,576 -416,719
Net Income -545,062 -657,939 -1,743,751 -427,505
Net Change In Cash 983,705 1,598,951 1,146,290 475,598
Cost of Revenue 884,813 564,443
Free Cash Flow -776,364 -508,922 265,460 -97,163
Cash 578,929 1,336,883 1,515,116 553,398
Basic Shares 100,768 78,183 74,400 57,554

Earnings Calls

Quarter EPS
2024-03-31 -$1.05
2023-12-31 -$1.44
2023-09-30 -$1.26
2023-06-30 $0.58